Conventus Flower Orthopedics
PrivateLast Round
M&A
May 27, 2020
Total Funding Raised
$55.5M
Company Overview
Conventus Flower Orthopedics operates in Healthcare & Life Sciences and is based in Horsham, Pennsylvania. Its latest recorded funding round was a Debt round in December 2018.
Conventus Flower Orthopedics is a medical devices company that develops and sells orthopedic solutions for fracture and corrective treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Conventus Flower Orthopedics Comparables
Compare Conventus Flower Orthopedics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skeletal Dynamics, Inc. | 79% | |
| Bonebridge AG | 78% | |
| Xenco Medical | 76% |
For institutional investors. Book with your work email.
Conventus Flower Orthopedics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 27, 2020 | ||||
| Debt | Dec 10, 2018 | ||||
| Debt | Dec 22, 2017 | ||||
| VC Round | May 9, 2017 | ||||
| VC Round | Nov 2, 2015 | ||||
Series C | Mar 23, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Conventus Flower Orthopedics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | VC Round, M&A, Series A Extension |
| Ally Bridge Group | VC Round, Series A Extension |
| Horizon Technology Finance Corporation | Debt |
| BioStar Capital | VC Round, Series A Extension |
| Alliance Healthcare Partners | Series C |
| Bluestem Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 99% MoM, reaching 2.1K.
- Mar 1, 2026
Monthly visitors grew 122% MoM, reaching 2K.
For institutional investors. Book with your work email.
Conventus Flower Orthopedics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Conventus Flower Orthopedics's valuation, stock price, and market status.
Is Conventus Flower Orthopedics a public or private company?
Conventus Flower Orthopedics is a private company.
What is the current stock price of Conventus Flower Orthopedics?
Conventus Flower Orthopedics is a private company, so its shares have no public market price. Caplight tracks Conventus Flower Orthopedics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Conventus Flower Orthopedics worth (valuation)?
Valuation information for Conventus Flower Orthopedics is not publicly available.
Can I buy Conventus Flower Orthopedics stock?
Conventus Flower Orthopedics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Conventus Flower Orthopedics's last funding round?
Conventus Flower Orthopedics's most recent funding round was M&A on May 27, 2020.
Who are the main investors in Conventus Flower Orthopedics?
Key investors in Conventus Flower Orthopedics include Deerfield Management, Ally Bridge Group, Horizon Technology Finance Corporation.
Will Conventus Flower Orthopedics IPO soon?
No public IPO plans have been announced for Conventus Flower Orthopedics.
How can I track Conventus Flower Orthopedics secondary market activity?
Caplight tracks bids, offers, and trades in Conventus Flower Orthopedics's shares on secondary markets.